Haga Hospital

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer. The center's work in mantle cell lymphoma and non-small cell lung cancer is particularly noteworthy, with ongoing trials exploring the efficacy of novel drug combinations and targeted therapies.

• Mantle Cell Lymphoma
• Non-Small Cell Lung Cancer
• Breast Cancer

Through these studies, the center aims to improve survival rates and quality of life for cancer patients by developing more effective and personalized treatment regimens.

Specializing in hematology, the center conducts cutting-edge research on blood disorders, including chronic lymphocytic leukemia and immune thrombocytopenia. The focus is on advancing therapeutic strategies that enhance patient outcomes and minimize treatment-related complications.

• Chronic Lymphocytic Leukemia
• Immune Thrombocytopenia
• AL Amyloidosis

By leveraging novel drug therapies and combination treatments, the center is committed to transforming the landscape of hematological care.

The center's cardiology research is pioneering new approaches to managing heart conditions, with a particular emphasis on heart failure and atrial fibrillation. These studies aim to refine treatment protocols and improve long-term cardiovascular health.

• Heart Failure with Reduced Ejection Fraction
• Atrial Fibrillation
• Cardiogenic Shock

Through innovative clinical trials, the center seeks to enhance therapeutic efficacy and patient quality of life in cardiovascular diseases.

In the field of neurology, the center is advancing research on multiple sclerosis and other neurological disorders. The focus is on developing therapies that target disease progression and improve neurological function.

• Multiple Sclerosis
• Idiopathic Ventricular Fibrillation

By exploring novel treatment modalities, the center aims to offer hope and improved outcomes for patients with complex neurological conditions.

The center is a leader in respiratory medicine, with significant research dedicated to cystic fibrosis and other pulmonary diseases. The goal is to enhance treatment efficacy and patient quality of life through innovative therapeutic approaches.

• Cystic Fibrosis
• Chronic Obstructive Pulmonary Disease

Through its research, the center is committed to advancing the understanding and management of respiratory conditions.